NCT07643415

Brief Summary

Open simple prostatectomy is still performed for selected patients with benign prostatic hyperplasia, particularly in cases with large prostate volume. Postoperative bleeding, hematuria, clot retention, and transfusion requirement are clinically important complications after this procedure. This prospective randomized controlled trial will compare the effects of spinal anesthesia and general anesthesia on postoperative bleeding in patients undergoing open simple prostatectomy. Participants will be randomized into two groups: spinal anesthesia or general anesthesia. Tranexamic acid or any additional hemostatic agent will not be used. Postoperative bleeding will be assessed using hemoglobin and hematocrit changes, transfusion requirement, hematuria, clot retention, need for bladder irrigation, and bleeding-related reintervention. The study aims to determine whether spinal anesthesia is associated with reduced postoperative bleeding compared with general anesthesia in open simple prostatectomy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Apr 2026Sep 2026

Study Start

First participant enrolled

April 29, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 8, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2026

Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

4 months

First QC Date

June 8, 2026

Last Update Submit

June 8, 2026

Conditions

Keywords

Open simple prostatectomy, spinal anesthesia, general anesthesia, postoperative bleeding

Outcome Measures

Primary Outcomes (1)

  • Clinically Significant Postoperative Bleeding

    Clinically significant postoperative bleeding is defined as the occurrence of at least one of the following events: Requirement for red blood cell transfusion; Hemoglobin decrease ≥2 g/dL accompanied by persistent gross hematuria and/or ongoing bladder irrigation; Clot retention requiring intensified bladder irrigation or endoscopic clot evacuation; Bleeding-related reintervention.

    Within 72 hours after surgery

Study Arms (2)

Spinal Anesthesia

ACTIVE COMPARATOR

Participants allocated to this arm will receive spinal anesthesia for open simple prostatectomy according to the institutional standard anesthesia protocol.

Procedure: Spinal anesthesia

General Anesthesia

ACTIVE COMPARATOR

Participants allocated to this arm will receive general anesthesia for open simple prostatectomy according to the institutional standard anesthesia protocol.

Procedure: General anesthesia

Interventions

Spinal anesthesia will be performed at the L3-4 or L4-5 interspace under aseptic conditions using hyperbaric bupivacaine. Light sedation may be administered when clinically required.

Spinal Anesthesia

General anesthesia will be induced and maintained according to the institutional standard protocol. Airway management, mechanical ventilation, anesthetic maintenance, antiemetic prophylaxis, and multimodal analgesia will be applied according to routine clinical practice.

General Anesthesia

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsThe study includes only male participants because benign prostatic hyperplasia and open simple prostatectomy are conditions and procedures specific to individuals with a prostate gland.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male patients aged 18 years or older.
  • Diagnosis of benign prostatic hyperplasia (BPH).
  • Scheduled to undergo open simple prostatectomy.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Ability to provide written informed consent.

You may not qualify if:

  • Refusal or inability to provide informed consent.
  • Patients scheduled for radical prostatectomy due to prostate cancer.
  • Emergency surgery.
  • Known coagulation disorders or clinically significant thrombocytopenia.
  • Ongoing anticoagulant or antiplatelet therapy that cannot be discontinued according to institutional protocols.
  • Contraindication to spinal anesthesia.
  • Participation in another interventional clinical trial that may affect study outcomes.
  • Administration of tranexamic acid or any additional hemostatic agent during the perioperative period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hitit university

Çorum, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Urologic NeoplasmsProstatic HyperplasiaPostoperative Hemorrhage

Interventions

Anesthesia, SpinalAnesthesia, General

Condition Hierarchy (Ancestors)

Urogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrologic DiseasesProstatic DiseasesGenital Diseases, MaleGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsPostoperative Complications

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Ozgur Yağan, Professor

    Hitit University

    STUDY CHAIR

Central Study Contacts

Mustafa Serdar Çağlayan

CONTACT

Sibel Onen Ozdemir

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

June 8, 2026

First Posted

June 11, 2026

Study Start

April 29, 2026

Primary Completion (Estimated)

August 15, 2026

Study Completion (Estimated)

September 15, 2026

Last Updated

June 11, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations